By | August 2, 2017

Makers of Blood Pressure Drug Benicar Settle 2,300 Lawsuits in a Federal N.J. Court

Daiichi Sankyo, Inc., a Tokyo-based drug maker worth an estimated $12.4 billion, agreed to settle nearly 2,300 patient lawsuits against its blood pressure medication Benicar® (olmesartan medoxomil) and its sister medications Benicar… Read More

By | July 18, 2017

FDA Pulls Addictive Opioid Pain Med off the Market as Lawsuits Against Pill Manufacturers Pile Up

On July 8 – in a first of its kind decision – the Food and Drug Administration (FDA) requested a pharmaceutical company to pull off the market one of its opioid products… Read More

By | July 14, 2017

Essure Patients Still Hope for Ban in U.S. After Suffering Years of Adverse Symptoms

Canada has just become the latest country to pull Essure off its market, as Brazil did this past February. While Brazil banned the product due to safety concerns, Bayer says it is… Read More

By | June 20, 2017

Did Sanofi-Aventis Lie About Taxotere Side Effects?

Despite more than $3 Billion in revenue, Taxotere® is not a household name – unless you are one of the 300,000 American women treated for breast cancer each year. About 75 percent… Read More

By | May 31, 2017

Tracking the Opioid Epidemic Back to Its Source

The death-toll of the opioid epidemic continues to set sinister records. For the third year in a row, Maine is looking at an all-time-high for overdose deaths. In 2016, the rural state… Read More

By | May 25, 2017

Consumers Beware: How ‘Approved’ Drugs Aren’t Always Safe

According to a study in the Journal of the American Medical Association (JAMA), of the 222 drugs that were approved by the Food and Drug Administration (FDA) from 2000 to 2010, 71… Read More

By | April 19, 2017

Big Pharma’s Deceitful Role in America’s Opioid Crisis

Tomorrow, barring significant changes, the Center for Disease Control (CDC) estimates that 91 Americans will die from an opioid overdose. That averages out to 3 people every hour, or 637 people per… Read More

By | November 22, 2016

FDA Mandates Boxed Warning, Patient Checklist for Essure

The U.S. Food and Drug Administration (FDA) recommended on Nov. 15 a boxed warning and a patient checklist that highlights possible adverse events associated with the use of Essure, Bayer’s permanent contraception… Read More

By | October 26, 2015

The History of Risperdal in the Pharmaceutical Marketplace

Also known by the generic name risperidone, Risperdal is a powerful, anti-psychotic medication prescribed to treat schizophrenia, autism and bipolar disorders in adults. Its manufacturer, Johnson & Johnson (J&J), has recently been making headlines,… Read More

By | July 16, 2015

Is Testosterone Replacement Therapy Safe? What You Need to Know

Did you know that testosterone is the most important sex hormone for men? It impacts multiple areas of health – including sex drive, energy, bone and muscle health, fertility and more. Below,… Read More